IBRN (iShares Neuroscience and Healthcare ETF) Stock Analysis

iShares Neuroscience and Healthcare ETF (IBRN) is a publicly traded the market company. As of May 21, 2026, IBRN trades at $28.16 with a market cap of $0 and a P/E ratio of 0.00. IBRN moved +0.89% today. Year to date, IBRN is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces IBRN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the latest IBRN stock research?

iShares Neuroscience and Healthcare ETF (IBRN) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. IBRN moved +0.89% today.

IBRN Key Metrics

Key financial metrics for IBRN
MetricValue
Price$28.16
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

IBRN Analyst Consensus

IBRN analyst coverage data. Average price target: $0.00.

Common questions about IBRN

What can I research for IBRN on Rallies?
iShares Neuroscience and Healthcare ETF (IBRN) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. IBRN moved +0.89% today.
Does Rallies show live market data for IBRN?
Rallies combines live market context with ticker research for IBRN, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.
IBRN

IBRN